Blog

How Can a Single Base Shape Cortical Folding? CCNB1IP1 Reveals a New Mechanism of Brain Development

📅 30 October.2026

Read More →

PODN and PODNL1: Emerging Target Genes with Potential Value in Disease Research

📅 20 August.2026

Read More →

CD33 Gene Editing Enters Clinical Testing in AML | A New CRISPR-Enabled Targeted Therapy Strategy

📅 18 August.2026

Read More →

Mitochondrial Energy Restoration + Ferroptosis Blockade: Next-Generation Nanotherapy Strategy for Stroke Recovery

📅 28 July.2026

Read More →

Beyond Natural Targeting Limits: Engineered Serine Integrases Advance Large DNA Knock-in

📅 21 July.2026

Read More →

CRISPR Lipid-Lowering Race Heats Up as Scribe Seeks $75 Million to Advance Epigenetic Silencing

📅 15 July.2026

Read More →

Cas12a2 CRISPR Breakthrough: RNA-Triggered Chromatin Shredding for Precision Cancer Cell Killing

📅 30 June.2026

Read More →

David Liu’s Team Reports Three Recent Prime Editing Breakthroughs: PERT, PE-PRISM, and LNP Delivery Advance Clinical Translation

📅 24 June.2026

Read More →

PCSK9 Gene Editing Advances: NEJM & Nature Medicine Clinical Insights and PCSK9 KO Cell Lines

📅 11 June.2026

Read More →

One Infusion, Permanent DNA Editing? CRISPR May Be Entering the Therapeutic Era

📅 28 May.2026

Read More →

Nature Breakthrough: Prime Assembly Enables Precise 11 kb Large DNA Insertions

📅 2 June.2026

Read More →

Rewriting CRISPR Rules: DNA-Guided Cas12a Enables Precise RNA Cleavage

📅 26 May.2026

Read More →

OptiPrime for Prime Editing: How David R. Liu's AI Model Improves pegRNA Design and Gene Therapy Efficiency

📅 6 March.2026

Read More →

CRISPR screening in human neurons reveals new insights into Alzheimer’s disease.

📅 12 February.2026

Read More →

Nobel Laureate Jennifer Doudna Launches Aurora Therapeutics to Scale Personalized CRISPR Therapies for Rare Diseases

📅 29 January.2026

Read More →